Fei-Jiao Ge

机构：Roche (China)

发表论文 36 篇 · 总被引 262 次 · h-index 8

代表论文

• PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer (2017 · Clinical Cancer Research · 被引 78)
• KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer (2014 · Journal of Experimental & Clinical Cancer Research · 被引 42)
• SKYSCRAPER-08: A phase III, randomized, double-blind, placebo-controlled study of first-line (1L) tiragolumab (tira) + atezolizumab (atezo) and chemotherapy (CT) in patients (pts) with esophageal squamous cell carcinoma (ESCC). (2024 · Journal of Clinical Oncology · 被引 31)
• Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature (2015 · Experimental and Therapeutic Medicine · 被引 29)
• A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma (2016 · Oncotarget · 被引 22)
• S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study (2014 · The Oncologist · 被引 21)